NCT06028477Not yet recruiting
Vibrotactile Coordinated Reset in Parkinson's Disease - Proof of Concept Study
Source: ClinicalTrials.gov · Last updated 19 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on Parkinson's symptoms. vCR will be administered with a device called the Stanford Glove. vCR is expected to provide patients with a non-invasive alternative to the most widely used treatments such as Levodopa and/or deep brain stimulation. Patients will be followed for 14 months.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 34 (estimated)
- First submitted
- 31 Aug 2023
- Start date
- 10 Jan 2025
- Primary completion date
- 30 Dec 2026
- Lead sponsor
- Stanford University
- Diseases
- Parkinson disease
- NCT number
- NCT06028477
What you commit to
- Study type: Interventional
- Planned participants: 34
- From 10 Jan 2025 to the primary completion date, 30 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participation in another drug, device, or biologics trial concurrently or within the preceding 30 days. Any other trial participation should be approved by the Principal Investigators.
Other
- Pregnancy, breast-feeding or wanting to become pregnant
- Physical limitations unrelated to PD that would affect motor ratings
- Has implantation of a medical device
- Sensory abnormalities of the fingertips
Who the study is looking for
- Ages 18 or older
- Diagnosed with idiopathic Parkinson's Disease
- Fluent in English
- Off-state UPDRS III motor score at least 30, as assessed within the past 6 months before study consent or at Screening Visit.
- Demonstrates understanding of the study requirements and is able and willing to sign the informed consent form and complete study procedures.
Age in the registry: 18 years to 92 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Stanford University Coordinator of this site? Confirm its status | Stanford | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.